Switzerland· 68262004
Treprostinil Ideogen 10 mg/mL, Infusionslösung
A treprostinil product containing treprostinilum, registered in Switzerland by IDEOGEN AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Treprostinil is registered in 17 of 19 countries.
Countries holding a registration under ATC B01AC21 (treprostinil), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Treprostinil · ATC B01AC21
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- treprostinilum
- Manufacturer
- IDEOGEN AG
- Country
- Switzerland (CH)
- ATC code
- B01AC21
- ATC class
- Treprostinil
- Defined daily dose
- 4.3 mg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680682620043Durchstf 20 mlCHF 12425.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
371 interactions on record for treprostinil.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Treprostinil · interactions on record
371 records
- 34 severe
- 295 moderate
- 2 minor
- 40 info
Most severe, free to view
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
- TinzaparinB01AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Treprostinil in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandRemodulinFerrer International S.A.
- United StatesRemodulinUnited Therapeutics Corporation
- CzechiaREMODULINFerrer Internacional, S.A., Barcelona
- SpainTREPROSTINILO DR REDDYS 10 MG/ML SOLUCION PARA PERFUSION EFGReddy Pharma Iberia S.A.
- BelgiumRemodulin 10 mg/mlFerrer Internacional
- SwedenRemodulin 10 mg/ml Infusionsvätska, lösningFerrer Internacional, SA.
- IcelandRemodulinFerrer Internacional S.A.
- NorwayRemodulinFerrer Internacional S.A.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Remodulin, Treposa
- Belgium · Remodulin, Tresuvi
- Bulgaria · Тресуви
- Cyprus · Remodulin
- Czechia · Remodulin, Treprostinil Tillomed
- Germany · Remodulin, Treprostinil Beta
- Denmark · Remodulin, Treprostinil Tillomed
- Estonia · Remodulin, Tresuvi
- Spain · Treprostinilo Dr. Reddys, Treprostinilo Ferrer
- Finland · Remodulin, Treposa
- France · Remodulin, Treposuvi
- United Kingdom (Northern Ireland) · Treprostinil Dr. Reddy's Laboratories (Uk), Treprostinil Tillomed
- Greece · Remodulin, Treprostinil Tillomed
- Croatia · Remodulin, Treprostinil Tillomed
- Hungary · Remodulin, Treprostinil Zentiva
- Ireland · Treposuvi, Treprostinil Tillomed
- Iceland · Remodulin, Trepulmix
- Italy · Remodulin, Treprostinil Dr. Reddy’s
- Liechtenstein · Trepulmix
- Lithuania · Remodulin, Treprostinil Tillomed
- Luxembourg · Remodulin
- Latvia · Remodulin, Treposuvi
- Malta · Tresuvi
- Netherlands · Remodulin, Treposuvi
- Norway · Remodulin, Treprostinil Tillomed
- Poland · Remodulin, Treprostinil Reddy
- Portugal · Remodulin, Treprostinilo Tillomed
- Romania · Tresuvi
- Sweden · Remodulin, Treprostinil Tillomed
- Slovenia · Remodulin, Treprostinil Amomed
- Slovakia · Remodulin, Treprostinil Tillomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1abbb74-3cc2-47fe-b47d-ffba9b6f137d GET /v1/drugs/d1abbb74-3cc2-47fe-b47d-ffba9b6f137d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "treprostinilum 200 mg",
"valid_from": "2022-11-01",
"limitations": "[{\"description\":\"Langzeitbehandlung von pulmonaler Hypertonie und pulmonal arterieller Hypertonie mit Bindegewebserkrankung bei Patienten mit NYHA III und IV (Einteilung nach der New York Heart Association).<br>\\nBei Patienten mit NYHA Class III bei Versagen der oralen und inhalativen Therapie.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-11-01\"}]",
"galenic_form": "Inf Lös 10 mg/ml",
"therapeutic_area": null,
"sl_inclusion_date": "2022-11-01",
"self_retention_pct": 10
}See everything about treprostinil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.